Señales en vivo de ARAY | Maximiza tus Ganancias con Getagraph.com

VENDER 113848 min ago

@ $2.73

Emitido: 14 feb 2024 @ 14:45

Retorno: -40.55%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: 0.93 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	1.52M
Volumen promedio	546 100
Capitalización de mercado	160.65M
EPS	$0 ( 2024-05-01 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.80
ATR14	$0.00600 (0.37%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Hoge Michael	Sell	11 991	Common Stock
2024-01-03	Pervaiz Ali	Sell	2 116	Common Stock
2024-01-03	Corradetti Gina	Sell	14 129	Common Stock
2023-11-30	Kill Robert	Buy	56 603	Common Stock
2023-12-01	Spine Patrick	Sell	14 832	Common Stock

INSIDER POWER
71.32
Last 97 transactions
Buy: 4 953 101 \| Sell: 644 284

Volumen Correlación

Largo: 0.26 (neutral)

Corto: 0.88 (strong)

Signal:(55.816) Same movement expected

Accuray Inc Correlación

10 Correlaciones Más Positivas
AUGX	0.946
BLU	0.943
LIQT	0.942
APOP	0.942
CPTA	0.941
TZOO	0.938
SYKE	0.936
EVCM	0.936
XLRN	0.934
CRNC	0.932

10 Correlaciones Más Negativas
PEAR	-0.937
VORB	-0.933
INFN	-0.931
SOPA	-0.929
ZENV	-0.929
LHDX	-0.926
IVAC	-0.922
OBNK	-0.92
TRIT	-0.919
MMAC	-0.919

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Accuray Inc Correlación - Moneda/Commodity

0.00
( neutral )

0.10
( neutral )

Accuray Inc Finanzas

Annual	2023
Ingresos:	$447.61M
Beneficio Bruto:	$153.96M (34.40 %)
EPS:	$-0.0978

FY	2023
Ingresos:	$447.61M
Beneficio Bruto:	$153.96M (34.40 %)
EPS:	$-0.0978

FY	2022
Ingresos:	$429.91M
Beneficio Bruto:	$159.96M (37.21 %)
EPS:	$-0.0581

FY	2021
Ingresos:	$396.29M
Beneficio Bruto:	$159.51M (40.25 %)
EPS:	$-0.0700

Financial Reports:

No articles found.

Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.